LOCALLY ADVANCED NSCLC79MO PACIFIC-R: Real-world characteristics of unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy
Under an Elsevier user license
open archive
Cited by (0)
Copyright © 2021 International Association for the Study of Lung Cancer. Published by Elsevier Inc. Published by Elsevier Inc. All rights reserved.